Derma Sciences (DSCI) Prelim. Q4, FY15 Sale Miss Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Derma Sciences (DSCI) Prelim. Q4, FY15 Sale Miss Views

Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance

January 7, 2016 7:30 AM EST

Reduces non-R&D operating expenses by approximately $10.0 million through workforce reductions, expense cuts and cost-savings initiatives Expects 13% AWC growth in 2016 and positive cash flow for the second half of the year

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, provides preliminary net sales for the year ended December 31, 2015, announces various actions to reduce operating expenses and introduces financial guidance for the year ending December 31, 2016.

For the year ended December 31, 2015:

... More